- EMEA Innovative Medicine
- About us
- Our responsibilities
- Sustainability
- Data Science – Data and AI are revolutionizing healthcare
Data Science – Data and AI are revolutionizing healthcare

Data science
You are now leaving jnj.com/innovativemedicine/emea
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.
You are now leaving jnj.com/innovativemedicine/emea
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.
AI and health data
AI and ethics
You are now leaving jnj.com/innovativemedicine/emea
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.
You are now leaving jnj.com/innovativemedicine/emea
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.
Empowering healthcare through data, Artificial Intelligence (AI) and digitalisation: policies for trust, innovation, and access.
We are committed to contributing to the digital transformation in healthcare through collaboration and partnership with all stakeholders.1 Implementing digital health requires a multi-faceted policy approach, where patients, citizens, policymakers, researchers, HCPs and industry work together to build a trustworthy and robust framework that keeps patients at the forefront and facilitates the development of digital solutions for better outcomes for patients.
Data is at the heart of what we do – from understanding the burden of disease and unmet needs, to delivering new treatments and quality healthcare services for patients and supporting value-based and sustainable healthcare systems. That is why we advocate for strong policies that support the use, access to and sharing of health data to build public trust, drive innovation, and foster sustainable health data ecosystems.
Our call includes:
- Building a European Health Data Space (EHDS) where all actors work together to improve patient outcomes, unlock the power of data science and foster innovation. EHDS should underpin a patient-centric health data ecosystem based on the full respect of ethics, privacy and security. To unleash the potential of data in delivery of care, electronic health records, and research and innovation, we need to ensure the EHDS provides access to correct data types for appropriate purposes. We need cost effective conditions for industry, while fully protecting data holders’ IP/trade secrets rights, and we advocate for a harmonised implementation across Member States.
1 Pharma AI Readiness Index: Who’s best-positioned for the AI boom? Available at:
https://www.cbinsights.com/research/ai-readiness-index-pharma/
You are now leaving jnj.com/innovativemedicine/emea This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use. You are now leaving jnj.com/innovativemedicine/emea This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
CP-516644
May 2025